tradingkey.logo
tradingkey.logo
検索

Zymeworks Inc

ZYME
ウォッチリストに追加
26.240USD
-0.230-0.87%
終値 11-13 16:00(ET)
1.85B時価総額
損失額直近12ヶ月PER

Zymeworks Incについて 企業名

Zymeworks Inc. is a global clinical-stage biotechnology company. The Company is developing a diverse pipeline of multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases such as cancer, autoimmune and inflammatory diseases (AIID). The Company engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s Azymetric technology. It has entered into separate agreements with BeiGene, Ltd. and Jazz Pharmaceuticals Ireland Limited, granting each exclusive rights to develop and commercialize zanidatamab in different territories. It is advancing a pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. The Company has two clinical-stage product candidates: ZW171 and ZW191. Its preclinical product candidates include ZW251, ZW220, ZW209, and ZW1528.

Zymeworks Inc プロフィール

企業コードZYME
会社名Zymeworks Inc
上場日Jun 24, 2019
最高経営責任者「CEO」Galbraith (Kenneth H)
従業員数280
証券種類Ordinary Share
決算期末Jun 24
本社所在地108 Patriot Drive, Suite A
都市MIDDLETOWN
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号19709
電話番号13022748744
ウェブサイトhttps://www.zymeworks.com/
企業コードZYME
上場日Jun 24, 2019
最高経営責任者「CEO」Galbraith (Kenneth H)

Zymeworks Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Hollywood
Mr. Mark Hollywood
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
133.85K
+0.70%
Mr. Gregory A. (Greg) Ciongoli
Mr. Gregory A. (Greg) Ciongoli
Independent Director
Independent Director
--
--
Ms. Suzanne Monahan
Ms. Suzanne Monahan
Senior Vice President, General Manager - Theravance Biopharma
Senior Vice President, General Manager - Theravance Biopharma
--
--
Ms. Kristin Stafford
Ms. Kristin Stafford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Lindsey Foulkes
Dr. Lindsey Foulkes
Senior Vice President - Corporate Development and Strategy
Senior Vice President - Corporate Development and Strategy
--
--
Ms. Bijal Desai
Ms. Bijal Desai
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Ms. Laura O'Connor
Ms. Laura O'Connor
Senior Vice President, Chief Human Resources Officer
Senior Vice President, Chief Human Resources Officer
--
--
Dr. Sabeen Mekan
Dr. Sabeen Mekan
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
--
Mr. Brian N. Cherry
Mr. Brian N. Cherry
Director
Director
--
--
Mr. Robert E. (Bob) Landry
Mr. Robert E. (Bob) Landry
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Hollywood
Mr. Mark Hollywood
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
133.85K
+0.70%
Mr. Gregory A. (Greg) Ciongoli
Mr. Gregory A. (Greg) Ciongoli
Independent Director
Independent Director
--
--
Ms. Suzanne Monahan
Ms. Suzanne Monahan
Senior Vice President, General Manager - Theravance Biopharma
Senior Vice President, General Manager - Theravance Biopharma
--
--
Ms. Kristin Stafford
Ms. Kristin Stafford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Lindsey Foulkes
Dr. Lindsey Foulkes
Senior Vice President - Corporate Development and Strategy
Senior Vice President - Corporate Development and Strategy
--
--
Ms. Bijal Desai
Ms. Bijal Desai
Senior Vice President - Finance
Senior Vice President - Finance
--
--

よくある質問

Zymeworks Incの上位5名の株主は誰ですか?

Zymeworks Incの上位5名の株主は以下のとおりです。Mr. Mark Hollywood
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。